<code id='5CA8022423'></code><style id='5CA8022423'></style>
    • <acronym id='5CA8022423'></acronym>
      <center id='5CA8022423'><center id='5CA8022423'><tfoot id='5CA8022423'></tfoot></center><abbr id='5CA8022423'><dir id='5CA8022423'><tfoot id='5CA8022423'></tfoot><noframes id='5CA8022423'>

    • <optgroup id='5CA8022423'><strike id='5CA8022423'><sup id='5CA8022423'></sup></strike><code id='5CA8022423'></code></optgroup>
        1. <b id='5CA8022423'><label id='5CA8022423'><select id='5CA8022423'><dt id='5CA8022423'><span id='5CA8022423'></span></dt></select></label></b><u id='5CA8022423'></u>
          <i id='5CA8022423'><strike id='5CA8022423'><tt id='5CA8022423'><pre id='5CA8022423'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:8
          Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT
          Alex Hogan/STAT

          Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

          NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

          advertisement

          Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

          DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          Bernie Sanders gets little from pharma CEOs on drug prices

          Sen.BernieSanders(I-Vt.)raiseshishandataThursdayhearingonCapitolHillinWashingtontoexaminethecostofpr